UNBLOCK: an open‐label, dose‐finding, pharmacokinetic and safety study of bivalirudin in children with deep vein thrombosis

Publisher： John Wiley & Sons Inc

E-ISSN： 1538-7836|13|9|1615-1622

ISSN： 1538-7933

Source： JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol.13, Iss.9, 2015-09, pp. : 1615-1622

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Open‐label prospective study of the safety and efficacy of glass‐based yttrium 90 radioembolization for infiltrative hepatocellular carcinoma with portal vein thrombosis

By  

CANCER, Vol. 121, Iss. 13, 2015-07 ,pp. : 2164-2174

John Wiley & Sons Inc

Access to resources Recommend Favorite

An open‐label extension long‐term study of the safety and efficacy of aripiprazole for irritability in children and adolescents with autistic disorder in Japan

By  

PSYCHIATRY AND CLINICAL NEUROSCIENCES, Vol. 72, Iss. 2, 2018-02 ,pp. : 84-94

John Wiley & Sons Inc

Access to resources Recommend Favorite

An Open-Label, Randomized, Flexible-Dose, Crossover Study to Assess the Comparative Efficacy and Safety of Sildenafil Citrate and Apomorphine Hydrochloride in Men with Erectile Dysfunction

By  

Urologia Internationalis, Vol. 81, Iss. 4, 2008-12 ,pp. : 409-415

Karger

Access to resources Recommend Favorite

Phase 1, open‐label, dose escalation, safety, and pharmacokinetics study of ME‐344 as a single agent in patients with refractory solid tumors

By  

CANCER, Vol. 121, Iss. 7, 2015-04 ,pp. : 1056-1063

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dynamic calibration of pharmacokinetic parameters in dose-finding studies

By O'quigley John   Hughes Michael D.   Fenton Terry   Pei Lixia  

Biostatistics, Vol. 11, Iss. 3, 2010-07 ,pp. : 537-545

Oxford University Press

Access to resources Recommend Favorite